LEVOKETOCONAZOLE | LEVOKETOCONAZOLE | ATC H02CA04
GENITO CORTISOL SYNTHESIS INHIBITOR INDICATED FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA CYTOCHROME CYP11B1 (11 BETA HYDROLASE), CYP11A1 (CHOLESTEROL SIDE-CHAIN CLEAVAGE) AND CYP17A1 (17 ALPHA HYDROLASE) INHIBITOR SUBSTRATE OF INTESTINAL AND LIVER P-GPP | ORAL | Tmax 1.75 HOUR VD 36 LITER PPB 99.3 PERCENT HT 3.75 HOUR SOLUBILITY VERY SLIGHTLY SOLUBLE IN WATER AT PH 2 | CYP11B1 CYP11A1 CYP17A1 | More at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |